Product Information

RIVASTIGMINE 4.5 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.1893 per EA under NDC 62135090260. Its NADAC has been published 180 times since Jun 14, 2023.

FDA first approved this application on Sep 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIVASTIGMINE 4.5 MG CAPSULE

Rivastigmine Tartrate
$0.1893per EA

Strength

4.5 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135090260

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA207797

FDA Approved

9/28/2017

TE Code

AB

On Market Since

9/28/2017

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for RIVASTIGMINE 4.5 MG CAPSULE has been published 180 times since Jun 14, 2023, and over the history we have for it it has declined 6.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1893 per EA
All-time high$0.2702 (Feb 14, 2024)
All-time low$0.1706 (Oct 21, 2026)
52-week high$0.2100
52-week low$0.1706
Median price$0.2034
Average price$0.2078
Largest weekly change-23.0% (Feb 21, 2024)
Weeks tracked180
Tracking sinceJun 14, 2023

Price History

1W

+11.0%

1M

+8.6%

3M

+1.3%

6M

-4.9%

1Y

-2.5%

3Y

-17.4%

5Y

N/A

All

-6.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIVASTIGMINE 4.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 4.5 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.1893 per EA (NDC 62135090260), effective Nov 18, 2026.

How has the price of RIVASTIGMINE 4.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has declined 6.6%. It has been tracked across 180 weekly CMS publications since Jun 14, 2023.

What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 4.5 MG CAPSULE?

Since Jun 14, 2023, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has ranged from a low of $0.1706 (Oct 21, 2026) to a high of $0.2702 (Feb 14, 2024), with a median of $0.2034 per EA.

Are there cheaper alternatives to RIVASTIGMINE 4.5 MG CAPSULE?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVASTIGMINE 4.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures RIVASTIGMINE 4.5 MG CAPSULE?

RIVASTIGMINE 4.5 MG CAPSULE (NDC 62135090260) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.